Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.arGEN-X advances ARGX-112 into preclinical development
The new human antibody ARGX-112 neutralizes both IL20 and IL22 signaling through blockade of their common receptor, IL22R, with low picomolar potency. IL20 and IL22 are involved in
The new human antibody ARGX-112 neutralizes both IL20 and IL22 signaling through blockade of their common receptor, IL22R, with low picomolar potency. IL20 and IL22 are involved in
The open-label, controlled dose-ranging study evaluated CCH’s safety and efficacy in treating Stage 2 unilateral idiopathic FSS against an exercise-only control group. The change (in degrees) from baseline
Under the agreement, BioTime will use LifeMap’s computer-based tools to extract information related to novel potential commercial products from approximately 100 million proprietary gene expression data points generated
Developed in partnership with Data Innovations, LabLink xL eliminates the requirement for installation of additional hardware or software through innovative internet-based technology. The Cloud Communicator is designed to
Tedizolid met all primary and secondary efficacy outcomes designated by the FDA and EMA in the ESTABLISH 2 intravenous (IV) to oral transition study. Trius president and chief
POMS systems eliminate errors and minimize incidents to provide web based production management control system, consulting and project management services to large pharmaceutical and biologics companies. RoviSys MES
Both the companies will equally finance €10m as an investment in the innovation of the industrial platform at Genzyme Polyclonals site in Lyon – Gerland area. Transgene chairman
New chemical entity acotiamide hydrochloride hydrate that inhibits peripheral acetylcholinesterase activities was invented by Zeria. Acofide works by suppressing the degradation of acetylcholine that is believed to play
LIFEROL is a protein-based bio-replenishment product, which addresses the dual nature of immune metabolism: bioavailability of nutrients (immune-specific amino acids) and functional availability of immune revitalizers and minerals
Empagliflozin belongs to sodium glucose co-transporter-2 (SGLT2) inhibitor class of drugs, which blocks glucose re-absorption in the kidney and eliminates excess glucose through the urine. Boehringer Ingelheim metabolic-clinical